- Home
- CORT vs VNOM Comparison
CORT vs VNOM Comparison
Compare CORT & VNOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CORT | VNOM |
|---|---|---|
| Founded | 1998 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.2B |
| IPO Year | 2001 | 2025 |
Fundamental Metrics
Financial Performance| Metric | CORT | VNOM |
|---|---|---|
| Price | $121.38 | $43.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 5 | 20 |
| Target Price | ★ $141.00 | $54.80 |
| AVG Volume (30 Days) | 872.9K | ★ 1.9M |
| Earning Date | 11-03-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 5.86% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.09 | ★ 1.27 |
| Revenue | $761,407,000.00 | ★ $1,395,000,000.00 |
| Revenue This Year | $50.53 | $79.22 |
| Revenue Next Year | $48.75 | N/A |
| P/E Ratio | $1,317.11 | ★ $33.57 |
| Revenue Growth | 12.79 | ★ 62.02 |
| 52 Week Low | $28.66 | $35.10 |
| 52 Week High | $126.38 | $51.13 |
Technical Indicators
Market Signals| Indicator | CORT | VNOM |
|---|---|---|
| Relative Strength Index (RSI) | 59.16 | 57.03 |
| Support Level | $108.33 | $42.51 |
| Resistance Level | $123.01 | $44.13 |
| Average True Range (ATR) | 5.11 | 0.95 |
| MACD | 0.39 | 0.27 |
| Stochastic Oscillator | 83.38 | 96.77 |
Price Performance
Historical ComparisonAbout CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic, and neuropsychiatric disorders by modulating the effect of the cortisol hormone. The company markets Korlym (mifepristone) tablets and its authorized generic version, which is an oral medication for the treatment of hypercortisolism (also known as Cushing's syndrome). Additionally, its pipeline contains several key compounds, such as Relacorilant, Dazucorilant, Miricorilant, etc., that are being evaluated in clinical trials as potential treatments for a variety of serious disorders like hypercortisolism, solid tumors (including ovarian, endometrial, cervical, pancreatic, and prostate cancers), ALS, and MASH.
About VNOM Viper Energy Inc.
Viper Energy Inc is focused on owning and acquiring mineral and royalty interests in oil and natural gas properties in the Permian Basin. The Permian Basin is known to have a number of zones of oil and natural gas-bearing rock throughout.